Detection and Prognosis of Prostate Cancer Using Blood-Based Biomarkers
Prostate cancer (PCa) is second only to lung cancer as a cause of death. Clinical assessment of patients and treatment efficiency therefore depend on the disease being diagnosed as early as possible. However, due to issues regarding the use of prostate-specific antigen (PSA) for screening purposes,...
Saved in:
Main Authors: | Wei Jin (Author), Xiang Fei (Author), Xia Wang (Author), Yan Song (Author), Fangjie Chen (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer
by: Xingyu Li, et al.
Published: (2024) -
The significance of angiogenesis in tumorigenesis and prognosis of prostate cancer
by: I. I. Yakovtcova, et al.
Published: (2017) -
The significance of angiogenesis in tumorigenesis and prognosis of prostate cancer
by: I. I. Yakovtcova, et al.
Published: (2017) -
Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer
by: Wanying Kang, et al.
Published: (2024) -
Emerging biomarkers in the diagnosis of prostate cancer
by: Filella X, et al.
Published: (2018)